Activist investor and billionaire David Einhorn’s 13F portfolio in the fourth quarter of 2021. Among the main new additions to the portfolio are Global Payments Inc., Intel Corporation, and Discovery, Inc. Between 2015 to late-2020, David Einhorn’s Greenlight Capital lost 34% of its value. Greenlight had only $1.1 billion with assets under management as of September 2021. With a return of 18.6 percent, the fund had one of its strongest quarters in previous years. Greenlight’s 13F portfolio’s value increased to $1.75 billion in Q4. The materials sector continues to be a stronghold for the fund. Einhorn believes that inflation will eventually lead to a recession, and he has set up the fund to prepare for this eventuality.
Insider Monkey highlights the top 10 stocks billionaire David Einhorn just added to his portfolio. During the fourth quarter, Greenlight Capital purchased a modest interest in Proterra Inc. In the zero-emission bus sector, the business is a market leader. During the fourth quarter, hedge fund manager David Einhorn bought shares in 23andMe Holding Co. On December 31, Greenlight was one of only 13 hedge funds long ME, half the number that were long in June. On December 31, Greenlight Capital was one of only seven hedge funds long Cassava Sciences, Inc., adding 40,620 shares to its position. Over the last two quarters, hedge fund ownership of SAVA has declined by 46%. During the fourth quarter, Greenlight Capital purchased 118,218 shares of Civitas Resources, Inc. During the fourth quarter, the company increased its daily average sales volume on a crude oil equivalent basis to 116,229 barrels, a 364 percent increase year over year. Another biotech business that David Einhorn has added to his 13F portfolio is Talis Biomedical Corp. During the quarter, Two Sigma Advisors and Tudor Investment Corp added new positions in TLIS, bringing the total number of hedge fund shareholders to seven from four. For more details, click Top 10 Stocks Billionaire David Einhorn Just Added To His Portfolio.